Maky Zanganeh

WORK HISTORY

EDUCATION

ABOUT MAKY ZANGANEH

Dr. Maky Zanganeh is a biotechnology executive, entrepreneur, and bestselling author. She serves as Co Chief Executive Officer and President of Summit Therapeutics. Her journey spans Iran, Germany, France, and the United States, where she has built a career focused on innovation and patient centered leadership.Before joining Summit Therapeutics, she served as Chief Operating Officer of Pharmacyclics, where she helped lead the development and commercialization of IMBRUVICA®, a breakthrough targeted therapy for B cell malignancies. Her leadership was instrumental in the company’s transformation and its eventual acquisition by AbbVie for 21 billion dollars, one of the largest biopharma transactions of the decade.Earlier in her career, she served as President of EMEA and Global Vice President of Training and Education at Computer Motion, where she helped expand robotic surgery worldwide. She played an integral role in Operation Lindbergh, the world’s first transatlantic robotic surgery.She is the author of The Magic of Normal published by Forbes Books in 2025, which became a bestseller and received a Gold Medal at the 2025 Global Book Awards. Her memoir shares her journey through war, displacement, global entrepreneurship, motherhood, and surviving breast cancer.Recognized by Forbes in 2025 as one of the self-made female billionaires in the United States, she is regarded as one of the most influential women in healthcare and biotechnology.Guided by the principle “Take responsibility and the ability will follow,” she is recognized for her decisive, patient centered leadership style and her ability to “collapse time” in delivering treatments to patients around the world.